Delivery Order SPE2DB20D1100-SPE2DB25FA7N2

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical products. The contract has a ceiling value of $2,902.03 and a period of performance through January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The contract has a ceiling value of $2,038.35 and a completion date of June 21, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medication. The contract has a ceiling value of $2,847.14 and a completion date of January 25, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, to support federal healthcare programs. The contract has a ceiling value of $3,692.58 and runs through January 27, 2025. It is a Firm Fixed Price contract and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,818.54, is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,438.16, is for the delivery of 4,563,728,508 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. It is a firm-fixed-price, delivery order contract with a completion date of February 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The award has a ceiling value of $4,818.46 and runs through January 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $1,527.23 and a performance period through December 11, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,608.21, is for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period through February 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The order has a firm fixed price of $1,279.38 and a period of performance through August 1, 2024. This contract is not designated as a set-aside. The award is made under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025 for a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA7N2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical products. The contract has a ceiling value of $3,996.32 and runs through February 26, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/27/25, 9:55 AM